OA 17.02 Updated Efficacy Results From the BIRCH Study: First-Line Atezolizumab Therapy in PD-L1–Selected Patients With Advanced NSCLC
暂无分享,去创建一个
R. Heist | F. Shepherd | L. Paz-Ares | L. Chow | A. Balmanoukian | A. Sandler | M. Reck | T. Kurata | J. Patel | E. Carcereny | J. Qiu | E. Felip | S. Mocci | S. Coleman